Refining Pharmacotherapy for Inferior Alveolar Nerve Injuries in Mandibular Fractures: A Pathophysiological and Evidence-Based Approach
Keywords:
Keywords: Inferior Alveolar Nerve, Mandibular Fracture, Neurosensory Disturbance, Pharmacotherapy, Nerve Regeneration, Neurotrophins, CorticosteroidsAbstract
Abstract: Inferior alveolar nerve (IAN) injury is a frequent and debilitating complication of mandibular fractures, leading to significant neurosensory dysfunction and a marked decline in patient quality of life. While surgical decompression and microsurgical repair form the cornerstone of management, the role of pharmacotherapy remains fragmented, largely empirical, and inconsistently applied. This article provides a comprehensive analysis of the pathophysiological cascades following IAN trauma, critically evaluates the current pharmacological armamentarium from corticosteroids and NSAIDs to neurotrophic agents and antioxidants and proposes a refined, mechanism-based, phased pharmacotherapeutic protocol. By aligning drug interventions with the temporal biology of nerve injury (acute inflammation, Wallerian degeneration, and regeneration), this review synthesizes evidence from preclinical models of peripheral nerve repair and clinical neurosensory studies to advocate for a standardized, multimodal approach. The goal is to create a neuroprotective and pro-regenerative microenvironment that complements surgical repair, minimizes persistent neuropathy, and accelerates functional sensory recovery.
References
1.Ellis, E., 3rd, Moos, K. F., & el-Attar, A. (1985). Ten years of mandibular fractures: an analysis of 2,137 cases. Oral Surgery, Oral Medicine, Oral Pathology, 59(2), 120–129.
2.Haug, R. H., Prather, J., & Indresano, A. T. (1990). An epidemiologic survey of facial fractures and concomitant injuries. Journal of Oral and Maxillofacial Surgery, 48(9), 926–932.
3.Marchena, J. M., Padwa, B. L., & Kaban, L. B. (1998). Sensory abnormalities associated with mandibular fractures: incidence and natural history. Journal of Oral and Maxillofacial Surgery, 56(7), 822–826.
4.Scholz, J., & Woolf, C. J. (2007). The neuropathic pain triad: neurons, immune cells and glia. Nature Neuroscience, 10(11), 1361–1368.
5.Stys, P. K. (2005). General mechanisms of axonal damage and its prevention. Journal of the Neurological Sciences, 233(1-2), 3–13.
6.Chen, Z. L., Yu, W. M., & Strickland, S. (2007). Peripheral regeneration.
7.[25.06.2026 17:39] Fardu: Annual Review of Neuroscience, 30, 209–233.
8.Barnes, P. J. (1998). Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clinical Science, 94(6), 557–572.
9.Galloway, E. B., 3rd, Jensen, R. L., Dailey, A. T., Thompson, B. G., & Shelton, C. (2000). Role of topical steroids in reducing dysfunction after nerve injury. Laryngoscope, 110(11), 1907–1910.
10.Tiwana, P. S., Foy, S. P., Shugars, D. A., et al. (2005). The impact of intravenous corticosteroids on the incidence of neurosensory disturbance following third molar surgery. Journal of Oral and Maxillofacial Surgery, 63(8 Suppl 1), 9.
11.Jiang, L., & Li, Z. (2013). Differential role of prostaglandin E2 receptors in nerve regeneration and pain. Neuroscience Bulletin, 29(5), 619–627.
12.Rich, K. M., Luszczynski, J. R., Osborne, P. A., & Johnson, E. M., Jr. (1987). Nerve growth factor protects adult sensory neurons from cell death and atrophy caused by nerve injury. Journal of Neurocytology, 16(2), 261–268.
13.Hobbenaghi, R., Javanbakht, J., Hosseini, E., et al. (2013). Neuropathological and neuroprotective features of methylcobalamin in a model of sciatic nerve injury. Folia Neuropathologica, 51(3), 238–245.
14.Stracke, H., Lindemann, A., & Federlin, K. (1996). A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy. Experimental and Clinical Endocrinology & Diabetes, 104(4), 311–316.
15.Stevens, M. J., Obrosova, I., Cao, X., Van Huysen, C., & Greene, D. A. (2000). Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes, 49(6), 1006–1015.
16.Ozay, R., Yuruker, S., Ozturk, A., et al. (2007). The effects of citicoline on peripheral nerve regeneration in a rat model. Journal of Reconstructive Microsurgery, 23(4), 211–216.
17.Fels, J. A., & Duman, R. S. (2012). Magnesium and the treatment of neuropathic pain. Neurochemical Research, 37(5), 847–858.
18.Plane, J. M., Shen, Y., Pleasure, D. E., & Deng, W. (2010). Prospects for minocycline neuroprotection. Archives of Neurology, 67(12), 1442–1448.